NT5E and Pulmonary hemorrhage: Here, three WT mice (15%), one CD39−/− mouse (5%), and three CD73−/− mice (15%) developed clinically overt pulmonary hemorrhage in response to pristane (and required euthanasia), all within 4 weeks of pristane administration (Figure 1B).